XKRX:032300 (Korea (the Republic of))
Â
Ordinary Shares
â‚©
16760.00
(+0.9%)
Nov 28
Business Description
Korea Pharma Co Ltd
ISIN : KR7032300006
Share Class Description:
XKRX:032300: Ordinary SharesCompare
Compare
Traded in other countries / regions
032300.Korea IPO Date
2020-08-10Description
Korea Pharma Co Ltd is a drug manufacturer. The company's products include amino acid drugs; antibiotic drugs; antidotal drugs; antiepileptic drugs; antihistamine drugs; anti-inflammatory drugs; antimicrobial drugs; antiplatelet drugs; circulatory system drugs; cns drugs; dermatological drugs; endocrine drugs; gastrointestinal drugs; hepatic drugs; hormonal drugs; multivitamins; respiratory drugs; skeltal muscle relaxants; specialty drugs; sympathomimetic drugs; and vitamin b1.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.71 | |||||
| Equity-to-Asset | 0.64 | |||||
| Debt-to-Equity | 0.31 | |||||
| Debt-to-EBITDA | 2.93 | |||||
| Interest Coverage | 1.82 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 4.52 | |||||
| Beneish M-Score | -2.55 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 1.3 | |||||
| 3-Year EBITDA Growth Rate | 6 | |||||
| 3-Year EPS without NRI Growth Rate | -70.9 | |||||
| 3-Year Book Growth Rate | 13.8 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 51.59 | |||||
| 9-Day RSI | 44.74 | |||||
| 14-Day RSI | 44.16 | |||||
| 6-1 Month Momentum % | 16.03 | |||||
| 12-1 Month Momentum % | 2.87 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.23 | |||||
| Quick Ratio | 3.11 | |||||
| Cash Ratio | 2.12 | |||||
| Days Inventory | 160.61 | |||||
| Days Sales Outstanding | 65.88 | |||||
| Days Payable | 66.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.3 | |||||
| Dividend Payout Ratio | 0.22 | |||||
| Forward Dividend Yield % | 0.3 | |||||
| 5-Year Yield-on-Cost % | 0.3 | |||||
| Shareholder Yield % | 14.18 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 43.48 | |||||
| Operating Margin % | 6.14 | |||||
| Net Margin % | 3.76 | |||||
| FCF Margin % | 4.8 | |||||
| ROE % | 4.41 | |||||
| ROA % | 2.47 | |||||
| ROIC % | 10.13 | |||||
| ROC (Joel Greenblatt) % | 10.87 | |||||
| ROCE % | 5.67 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 61.17 | |||||
| PE Ratio without NRI | 69.61 | |||||
| PS Ratio | 2.3 | |||||
| PB Ratio | 2.56 | |||||
| Price-to-Tangible-Book | 2.7 | |||||
| Price-to-Free-Cash-Flow | 54.78 | |||||
| Price-to-Operating-Cash-Flow | 31.67 | |||||
| EV-to-EBIT | 14.39 | |||||
| EV-to-EBITDA | 12.17 | |||||
| EV-to-Revenue | 2.07 | |||||
| EV-to-FCF | 43.39 | |||||
| Price-to-Graham-Number | 3 | |||||
| Price-to-Net-Current-Asset-Value | 4.98 | |||||
| Earnings Yield (Greenblatt) % | 6.95 | |||||
| FCF Yield % | 1.85 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Korea Pharma Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 79,798.733 | ||
| EPS (TTM) (â‚©) | 275.556 | ||
| Beta | 1.3 | ||
| Volatility % | 41.43 | ||
| 14-Day RSI | 44.16 | ||
| 14-Day ATR (â‚©) | 1182.781615 | ||
| 20-Day SMA (â‚©) | 17162.5 | ||
| 12-1 Month Momentum % | 2.87 | ||
| 52-Week Range (â‚©) | 14550 - 29450 | ||
| Shares Outstanding (Mil) | 10.91 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Korea Pharma Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Korea Pharma Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Korea Pharma Co Ltd Frequently Asked Questions
What is Korea Pharma Co Ltd(XKRX:032300)'s stock price today?
The current price of XKRX:032300 is â‚©16760.00. The 52 week high of XKRX:032300 is â‚©29450.00 and 52 week low is â‚©14550.00.
When is next earnings date of Korea Pharma Co Ltd(XKRX:032300)?
The next earnings date of Korea Pharma Co Ltd(XKRX:032300) is .
Does Korea Pharma Co Ltd(XKRX:032300) pay dividends? If so, how much?
The Dividend Yield %  of Korea Pharma Co Ltd(XKRX:032300) is 0.3% (As of Today), Highest Dividend Payout Ratio of Korea Pharma Co Ltd(XKRX:032300) was 6.25. The lowest was 0.09. And the median was 0.15. The  Forward Dividend Yield % of Korea Pharma Co Ltd(XKRX:032300) is 0.3%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers